Angiography Catheters Market to Expand from USD 1.75 Billion in 2025 to USD 3.59 Billion by 2034

The global angiography catheters market was valued at USD 1.75 billion in 2025 and is projected to grow from USD 1.90 billion in 2026 to USD 3.59 billion by 2034, registering a CAGR of 8.3% during 2026–2034. North America dominated the market with a 38.5% share in 2025, while Asia Pacific is expected to register the fastest CAGR of 8.9%.

Market Size (2025): USD 1.75 Billion
Market Size (2026): USD 1.90 Billion
CAGR (Forecast Period): 8.3%
Forecast Year: 2034
Projected Market Size (2034): USD 3.59 Billion
Dominant Region: North America – 38.5%
Fastest Growing Region: Asia Pacific – 8.9% CAGR
Market Overview
Angiography catheters are thin, flexible medical devices used to deliver contrast media into blood vessels during angiographic imaging. Their applications span cardiovascular, peripheral vascular, neurovascular, and oncology procedures, with hospitals and specialized healthcare facilities representing major areas of utilization.

Growth Drivers
The wider use of catheter-based vascular procedures is supporting utilization of angiography catheters across cardiovascular, peripheral vascular, and other interventions. Growing adoption of radial-access procedures is also encouraging manufacturers to develop catheter designs with appropriate length, flexibility, torque control, and deliverability for wrist-based procedures.

Market Challenges
Maintaining high-flow contrast delivery within a small catheter diameter remains a key engineering challenge. Manufacturers must balance lumen size with flexibility, kink resistance, torque response, wall strength, and pressure tolerance while maintaining suitable navigation through complex vascular anatomy.

Market Opportunities
Application-specific catheter designs for pulmonary and right-heart procedures create opportunities for manufacturers to expand beyond general-purpose diagnostic products. Specialized balloon-equipped designs and strategically positioned side holes can support contrast distribution, pressure measurement, and occlusion angiography in targeted procedures.

Segment Analysis
By product, conventional catheters dominated the angiography catheters market with a 47.3% share in 2025, supported by their established use in diagnostic angiography and the availability of multiple configurations for selective vascular access.

By application, oncology is projected to register the fastest CAGR of 7.9% during 2026–2034, supported by catheter-directed interventional oncology procedures such as embolization and chemoembolization.

By end user, hospitals accounted for the largest share of 62.4% in 2025, reflecting their role in complex angiographic procedures requiring specialized equipment, multidisciplinary teams, and post-procedure care.

Regional Analysis
North America led the angiography catheters market with a 38.5% share in 2025, supported by an established interventional cardiology infrastructure and a mature base of diagnostic catheterization and percutaneous coronary intervention procedures.

Asia Pacific is projected to record the fastest CAGR of 8.9% during 2026–2034, supported by the wider availability of catheter-based cardiovascular, peripheral vascular, and neurovascular interventions. Japan's extensive PCI registry infrastructure and China's expanding use of catheterization laboratories across multiple specialties further support regional development.

Europe accounted for 27.4% of the market in 2025 and is expected to grow at a CAGR of 6.5%, supported by structured clinical governance and quality-assurance systems surrounding coronary angiography and PCI. Latin America represented 6.7% and is projected to grow at 7.1%, while the Middle East and Africa accounted for 4.8% and is forecast to expand at 6.4%.

Competitive Landscape
The angiography catheters market is highly competitive, with medical device companies focusing on catheter flexibility, deliverability, torque control, radiopacity, radial-access capabilities, and low-profile designs. Product innovation is increasingly centered on improving procedural control and navigation across complex vascular anatomy.

Key companies include:

Medtronic
Boston Scientific Corporation
Terumo Medical Corporation
Merit Medical Systems
AngioDynamics
Cardinal Health
B. Braun Melsungen AG
Becton, Dickinson and Company
Alvimedica
Teleflex Incorporated
Recent Developments
In May 2026, Terumo Interventional Systems launched an expanded portfolio of high-torque angiography catheters designed to improve trackability, pushability, and procedural efficiency. In March 2026, Merit Medical Systems received U.S. FDA 510(k) clearance for a new angiographic catheter designed for vascular access and contrast delivery.

In December 2025, Teleflex introduced a next-generation angiography catheter featuring an optimized braided shaft and hydrophilic coating, while Boston Scientific expanded its interventional cardiology portfolio in September 2025 with advanced diagnostic angiography catheters.

Future Outlook
The angiography catheters market is expected to maintain strong growth through 2034 as catheter-based vascular interventions expand across cardiovascular, peripheral, neurovascular, and oncology applications. Transradial access, specialized catheter configurations, digital physiology assessment, and low-profile designs are expected to influence product development and competitive strategies.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/angiography-catheters-market

About
Straits Research is a global market intelligence and consulting company providing market research, strategic insights, competitive analysis, and advisory services across multiple industries. The company delivers research and consulting solutions that help businesses understand market dynamics, evaluate competitive environments, identify opportunities, and support informed strategic decisions.